Artemis Hospitals
| Indien | Türkei | Österreich | |
| Whipple-Operation | von $7,500 | von $23,000 | von $45,000 |
| Uterustrachelektomie | von $4,500 | von $5,500 | von $14,500 |
| Strahlentherapie bei Darmkrebs | von $3,200 | von $7,000 | von $12,000 |
| Robotische da Vinci-Prostatektomie | von $7,500 | von $17,000 | von $20,000 |
| Protonentherapie bei Prostatakrebs | von $35,000 | von $30,000 | von $80,000 |
Bookimed erhebt keine zusätzlichen Gebühren für Adenokarzinom-Behandlungspreise. Die Preise stammen aus den offiziellen Preislisten der Kliniken. Sie zahlen direkt in der Klinik für Ihre Behandlung bei Ihrer Ankunft im Land.
Bookimed setzt sich für Ihre Sicherheit ein. Wir arbeiten nur mit medizinischen Einrichtungen zusammen, die hohe internationale Standards bei der Behandlung von Adenokarzinom einhalten und über die notwendigen Lizenzen verfügen, um internationale Patienten weltweit zu behandeln.
Bookimed bietet kostenlose fachliche Unterstützung. Ein persönlicher medizinischer Koordinator unterstützt Sie vor, während und nach Ihrer Behandlung und hilft Ihnen bei allen Fragen. Sie sind auf Ihrer Adenokarzinom-Behandlungsreise nie allein.
Dr. Shruti Kate ist auf die Behandlung von Lungen-, Brust- und gynäkologischen Krebserkrankungen spezialisiert, wobei ihr Schwerpunkt auf Immuntherapie und metronomischer Therapie liegt. Sie wurde am Tata Memorial Hospital ausgebildet, einem der führenden Krebszentren Indiens.
Dr. Borde hat im HCG Manavata Cancer Centre über 30.000 PET-Scans durchgeführt und 1.000 Patienten mit Schilddrüsenkrebs behandelt.
Dr. Sridhar P.S. ist auf Strahlentherapie bei Adenokarzinomen spezialisiert und verfügt über mehr als 18 Jahre Erfahrung am HCG Manavata Cancer Centre.
Indian oncologists treating adenocarcinoma frequently hold international accreditations from respected global organizations. Many specialists earn certifications from the European Society for Medical Oncology (ESMO) or the American Society of Clinical Oncology (ASCO). Leading facilities maintain Joint Commission International (JCI) standards for safety.
Bookimed Expert Insight: Quality signals in India often follow a hub-and-spoke pattern. Major medical hubs like Gurgaon and Chennai house hospitals like Fortis and Global Hospital. These facilities report massive volumes, sometimes serving over 80,000 patients annually. Our data shows that high-volume surgeons, such as those at HCG Manavata with over 50,000 procedures, are those most likely to hold multiple international fellowships.
Patient Consensus: Patients note it is vital to travel to major cities for accredited care. They emphasize that video consultations help verify a doctor's global credentials before traveling.
India enforces safety for chemotherapy and radiation through statutory regulations from the Atomic Energy Regulatory Board and the National Cancer Grid. Facilities like Global Hospital Chennai and Manipal Hospital maintain JCI and NABH accreditations. These standards mandate precise tumor targeting and strict waste management protocols.
Bookimed Expert Insight: Quality indicators for safety are closely tied to specialist experience and clinical volume rather than just equipment. At HCG Manavata Cancer Centre, specialists like Dr. Raj Nagarkar have performed over 50,000 surgeries. This massive clinical volume allows institutions to refine safety checklists that common regulations might overlook.
Patient Consensus: Patients note that safety standards can vary significantly between facility tiers. They emphasize checking for current NABH or JCI accreditations before starting any long-term oncology treatment.
Indian oncology centers manage adenocarcinoma side effects using protocols from the National Cancer Grid and international standards. Support involves preventive nausea control with serotonin antagonists and specialized radiation skin care. Facilities like Artemis Hospitals and Medanta follow strict monitoring for toxicity and blood counts.
Bookimed Expert Insight: High-volume centers like HCG Manavata Cancer Centre, which serves 75,000 patients annually, integrate surgical and medical expertise to preemptively manage toxicity. Specialists like Dr. Raj Nagarkar have performed over 50,000 surgeries, emphasizing that experienced clinical teams often catch side effects earlier than smaller facilities. This proactive monitoring is key in large, JCI-accredited Indian hospitals.
Patient Consensus: Patients emphasize starting mouth and skin care regimens on day 1 to prevent severe reactions. Many suggest using natural alternatives like ginger tea for nausea and curd rice for managing digestive issues during radiation.
Smaller Indian cities like Nashik, Mohali, and Nadiad offer the shortest wait times for adenocarcinoma surgery. Private facilities in these hubs often schedule robotic or laparoscopic procedures in under 7 days. Major metros like Gurgaon and Bangalore maintain high-capacity systems with 7 to 20-day access.
Bookimed Expert Insight: While major metros have more robots, tier-2 cities like Nashik provide faster surgical slots due to lower international patient density. Dr. Raj Nagarkar in Nashik has performed over 50,000 surgeries. This high individual volume in smaller hubs often ensures both speed and significant surgical expertise.
Patient Consensus: Patients find that booking multiple consultations in cities like Mumbai or Delhi can secure a robotic slot within 10 days. Those choosing underrated hubs like Hyderabad report getting surgery dates in as little as 5 days post-biopsy.
A full adenocarcinoma treatment cycle in India typically requires 4 to 12 weeks. Stays vary by modality: surgery alone takes 2 to 6 weeks, while radiation requires 3 to 6 weeks. Combined protocols involving chemotherapy and surgery often extend stays to 3 months for safety.
Bookimed Expert Insight: High-volume centers like HCG Manavata or Global Hospital serve up to 80,000 patients yearly. This massive volume allows them to offer fast-track diagnostic bundles. Patients can often complete CT scans and oncology consultations within 48 hours. Using centers with 40+ staff oncologists typically shortens the pre-treatment phase by at least 1 week.
Patient Consensus: Patients note that lung or breast cancer cycles often hit the 10-week mark. It is important to pack for 2 months and book flexible flights to account for recovery buffers.
Continuing targeted therapy in India is generally feasible. Standard treatments like immunotherapy or tyrosine kinase inhibitors are available at major oncology centers. Global clinical trials however require specific approval from the study sponsor. The Indian facility must already be a registered site for that trial.
Bookimed Expert Insight: Private oncology centers in India offer a significant advantage for continuing complex care. Specialized facilities like HCG Manavata Cancer Centre participate in over 200 clinical trials. Dr. Raj Nagarkar there has extensive experience managing phase 1-3 studies. Choosing a center with high trial volume ensures the infrastructure for protocol continuity exists.
Patient Consensus: Patients note that switching trials often requires re-enrollment rather than a seamless transfer. Accessing targeted drugs is easier if you budget for potential 4–6 week import delays at customs.